“…Blood pressure reducing peptides which inhibit the angiotensin converting enzyme I (ACE) are most studied (Li et al, 2004;Meisel et al, 2006;Murray & FitzGerald, 2007;Saito, 2008). Casein hydrolysates have in some studies produced higher ACE-inhibitory activity than whey protein hydrolysates but also whey peptides such as Ala-Leu-ProMet-His-Ile-Arg (ALPMHIR) from tryptic digest of b-lg have been identified with strong antihypertensive activity (Mullally et al, 1997;Maes et al, 2004;Ferreira et al, 2007). Also other proteolytic enzymes, such as Alcalase, Thermolysin, Subtilisin and successive treatment with pepsin and trypsin in order to simulate gastrointestinal digestion have been employed to release various bioactive peptides, including CCPs (McDonagh & FitzGerald, 1998), ACE inhibitory (Pihlanto-Leppä lä et al, 2000;Vermeirssen et al, 2004;Roufik et al, 2006;deCosta et al, 2007), antibacterial (Ló pez-Expó sito & Recio, 2006;Ló pez-Expó sito et al, 2007), antioxidative (Pihlanto, 2006) immunomodulatory and opioid-like (Teschemacher, 2003).…”